Difference between revisions of "NSAIDs"
Jump to navigation
Jump to search
Tags: Mobile web edit Mobile edit |
|||
| Line 1: | Line 1: | ||
* e.g. Ibuprofen, Naproxen, Ketorolac | * e.g. Ibuprofen, Naproxen, Ketorolac | ||
| − | * | + | * Renally excreted. Acts on COX 1/2. Inhibits renal production of prostaglandins. |
| − | * Safe for short term use in patients with stage 1-2 CKD. Risk of causing AKI is same as in general population. No evidence that it will increase risk of progression. | + | * Safe for short term use in patients with stage 1-2 [[CKD]]. Risk of causing [[AKI]] is same as in general population. No evidence that it will increase risk of progression. |
* Schedule NSAIDs, if they are only PRNs they likely won’t happen. | * Schedule NSAIDs, if they are only PRNs they likely won’t happen. | ||
| + | * Topical = Diclofenac gel (Voltaren). | ||
Latest revision as of 13:48, 2 August 2022
- e.g. Ibuprofen, Naproxen, Ketorolac
- Renally excreted. Acts on COX 1/2. Inhibits renal production of prostaglandins.
- Safe for short term use in patients with stage 1-2 CKD. Risk of causing AKI is same as in general population. No evidence that it will increase risk of progression.
- Schedule NSAIDs, if they are only PRNs they likely won’t happen.
- Topical = Diclofenac gel (Voltaren).